New Faculty Member

The Boston University Alzheimer's Disease Center (BU ADC) is pleased to welcome Lee E. Goldstein, MD, PhD as a new research affiliate of the BU ADC. Dr. Goldstein was recently recruited to Boston University from Harvard Medical School and the Brigham & Women's Hospital, where he was Director of the Molecular Aging & Development Laboratory and the Center for Biometals & Metallomics.

Dr. Goldstein and his team transitioned to the Boston University School of Medicine, College of Engineering, and Photonics Center this past fall. Dr. Goldstein is joining the faculty in the departments of Psychiatry, Ophthalmology, Neurology, Pathology & Laboratory Medicine, Biomedical Engineering, and Photonics. He will continue to direct his research program from two Boston University laboratories, the first at the new BioSquare Research Park on the Boston Medical Center campus and the second at the Photonics Center in the Engineering complex on the Charles River campus.

Dr. Goldstein completed his undergraduate studies at Columbia University and received a joint MD/PhD degree from Yale University. His team's research focuses on understanding the role of abnormal protein aggregation in chronic degenerative disorders of aging, including Alzheimer's disease (AD), age-related cataracts, and other common diseases of aging that involve pathogenic protein aggregation. He and his laboratory are developing innovative laser-based molecular diagnostic technology for early pre-symptomatic detection and screening of AD. Dr. Goldstein is a founder, director, and consultant to Neuroptix, a leading laser diagnostic company based in Acton, MA.

• Alfred Davis Receives Prestigious Award
• PAIRS Program Provides Education Outside Classroom
• American Academy of Neurology Meeting
• New Faculty Member
• Research Update
• StoryCorps Visits Boston University
• Greater Boston Memory Walk
• Actively Recruiting Studies
• BU ADC Happenings
• Save the Date
• Honorary and Memorial Contributions